Pfizer (PFE) Prepaid Assets (2009 - 2026)
Pfizer (PFE) reported Prepaid Assets of $2.9 billion for Q1 2026, down 1.32% year-over-year from $2.9 billion in Q1 2025, and up 3.56% quarter-over-quarter from $2.8 billion in Q4 2025.
Pfizer (PFE) Prepaid Assets (2009 - 2026) Analysis & Trends
Pfizer (PFE) has 16 years of Prepaid Assets data on file, last reported at $2.9 billion in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $2.9 billion, down 1.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 1.32% YoY), and the FY2025 annual result was $2.8 billion, down 33.98% from the prior year.
- Prepaid Assets grew to $2.9 billion in Q1 2026 per PFE's latest filing, from $2.8 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.1 billion in Q4 2022 and troughed at $2.4 billion in Q3 2025.
- A 5-year average of $4.2 billion and a median of $4.3 billion in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 62.24% in 2022, then tumbled 38.83% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $5.0 billion in 2022, then slipped by 2.11% to $4.9 billion in 2023, then fell by 13.4% to $4.3 billion in 2024, then tumbled by 33.98% to $2.8 billion in 2025, then climbed by 3.56% to $2.9 billion in 2026.
- Business Quant data shows PFE's Prepaid Assets at $2.9 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 2.91 Bn |
| Dec 31, 2025 | 2.81 Bn |
| Sep 28, 2025 | 2.36 Bn |
| Jun 29, 2025 | 2.69 Bn |
| Mar 30, 2025 | 2.95 Bn |
| Dec 31, 2024 | 4.25 Bn |
| Sep 29, 2024 | 3.86 Bn |
| Jun 30, 2024 | 4.19 Bn |
| Mar 31, 2024 | 4.37 Bn |
| Dec 31, 2023 | 4.91 Bn |
| Oct 1, 2023 | 4.62 Bn |
| Jul 2, 2023 | 4.83 Bn |
| Apr 2, 2023 | 5.12 Bn |
| Dec 31, 2022 | 5.02 Bn |
| Oct 2, 2022 | 6.15 Bn |
| Jul 3, 2022 | 5.97 Bn |
| Apr 3, 2022 | 4.20 Bn |
| Dec 31, 2021 | 3.82 Bn |
| Oct 3, 2021 | 3.79 Bn |
| Jul 4, 2021 | 3.82 Bn |